Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23779694 | 1.00 | MEN1 (0.30) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL23779695 | 1.00 | MEN1 (0.30) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL23779690 | 1.00 | MEN1 (0.30) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL23779689 | 0.95 | — | — | |
| SCHEMBL23779683 | 0.95 | — | — | |
| SCHEMBL23779686 | 0.95 | — | — | |
| SCHEMBL23779681 | 0.95 | — | — | |
| SCHEMBL23779682 | 0.95 | MEN1 (0.30) | MEN1THRBHTTKMT2AMAPT | |
| SCHEMBL23779680 | 0.90 | — | — | |
| SCHEMBL23779691 | 0.84 | MEN1 (0.30) | MEN1THRBHTTKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12091491-B2 | Silylamine compound and latent curing agent comprising said silylamine compound | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2024-09-17 | — | — | US | disclosed |
| US-20220119583-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2022-04-21 | — | — | US | disclosed |
| EP-3875461-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | Koei Chemical Company, Limited (JP) | 2021-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119583-A1 | SILYLAMINE COMPOUND AND LATENT CURING AGENT COMPRISING SAID SILYLAMINE COMPOUND | CDKN1A, SIRT2, H1-4 | MEN1 2165/4885THRB 4582/4885HTT 4234/4885 |
| US-12091491-B2 | Silylamine compound and latent curing agent comprising said silylamine compound | CDKN1A, SIRT2, H1-4 | MEN1 2165/4885THRB 4582/4885HTT 4234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.